Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
boston top stories
drugs
2
×
life sciences
national blog main
akcea therapeutics
allergan
alnylam pharmaceuticals
biotech
clinical trials
crispr
cynthia collins
editas medicine
european medicines agency
fda
gene editing
harvard pilgrim health care
hereditary transthyretin amyloidosis
inotersen
institute for clinical and economic review
katrine bosley
leber congenital amaurosis
national top stories
new york blog main
new york top stories
onpattro
patisiran
pfizer
san diego blog main
san diego top stories
tafamidis
What
gene
2
×
medicine
allergan
alnylam
approves
blessing
bosley
cells
ceo
check
clinical
crispr
cusp
depart
drug
editas
editing
ema
employ
europe
experimental
fda
follows
harmful
hits
humans
interference
katrine
make
method
million
mute
partner
protein
regulatory
rna
rnai
test
therapy
trial
Language
Current search:
gene
×
boston
×
drugs
×
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
